CH
CRGX

CVI Holdings’s CARGO Therapeutics CRGX Stock Holding History

CVI Holdings’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.15M Buy
+70,000
New +$1.33M 0.99% 16

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

CVI Holdings's CRGX Position: Q2 2024 in Review

CVI Holdings opened a new position in CARGO Therapeutics (CRGX) in Q2 2024: 70,000 shares worth $1.15M. The stake represents 0.99% of the portfolio and ranks #16 among its holdings.

73 funds tracked by Wall St. Rank hold CRGX as of Q2 2024.

  • CVI Holdings held 70,000 shares of CARGO Therapeutics worth $1.15M as of Q2 2024.
  • CARGO Therapeutics was a new CVI Holdings position in Q2 2024.
  • CARGO Therapeutics made up 0.99% of CVI Holdings's portfolio in Q2 2024, its #16 holding.
  • 73 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.